Authors: | Pervan, C. L.; Lautz, J. D.; Blitzer, A. L.; Langert, K. A.; Stubbs, E. B., Jr |
Article Title: | Rho GTPase signaling promotes constitutive expression and release of TGF-beta2 by human trabecular meshwork cells |
Abstract: | Elevated intraocular pressure (IOP) is causally implicated in the pathophysiology of primary open-angle glaucoma (POAG). The molecular mechanisms responsible for elevated IOP remain elusive, but may involve aberrant expression and signaling of transforming growth factor (TGF)-beta2 within the trabecular meshwork (TM). Consistent with previously published studies, we show here that exogenous addition of TGF-beta2 to cultured porcine anterior segments significantly attenuates outflow facility in a time-dependent manner. By comparison, perfusing segments with a TGFbetaRI/ALK-5 antagonist (SB-431542) unexpectedly elicited a significant and sustained increase in outflow facility, implicating a role for TM-localized constitutive expression and release of TGF-beta2. Consistent with this thesis, cultured primary or transformed (GTM3) quiescent human TM cells were found to constitutively express and secrete measurable amounts of biologically-active TGF-beta2. Disrupting monomeric GTPase post-translational prenylation and activation with lovastatin or GGTI-298 markedly reduced constitutive TGF-beta2 expression and release. Specifically, inhibiting the Rho subfamily of GTPases with C3 exoenzyme similarly reduced constitutive expression and secretion of TGF-beta2. These findings suggest that Rho GTPase signaling, in part, regulates constitutive expression and release of biologically-active TGF-beta2 from human TM cells. Localized constitutive expression and release of TGF-beta2 by TM cells may promote or exacerbate elevation of IOP in POAG. |
Journal Title: | Experimental eye research |
Volume: | 146 |
ISSN: | 1096-0007; 0014-4835 |
Publisher: | Unknown |
Date Published: | 2015 |
Start Page: | 95 |
End Page: | 102 |
Language: | ENG |
DOI/URL: |
S0014-4835(15)30095-6 |
Notes: | LR: 20160411; CI: Published by Elsevier Ltd.; JID: 0370707; OTO: NOTNLM; 2015/08/05 [received]; 2015/12/15 [revised]; 2015/12/22 [accepted]; aheadofprint |